Transplant Patients Need Anti-Rejection Drugs. Why Won’t Insurers Pay for Some of Them? by GINA KOLATA


Drugs to prevent organ rejection are not always covered for patients who had transplants before they enrolled in Medicare.

Published: April 2, 2019 at 02:00AM

from NYT Health https://ift.tt/2CQNI7l